CHG-2022-0271

Analytical Method Change for Kcluximab. Facility Change for Kcluximab — minor update. Impacts 4 markets and 5 variations.

Change Number
CHG-2022-0271
Type
Analytical Method Change
Product
Kcluximab
Status
In Progress
Owner
Carlos Mendez
Initiated
2023-05-06
Description

Facility Change for Kcluximab — minor update

Impacted Markets (4)
EU — European UnionSG — SingaporeRU — RussiaAT — Austria
Impacted Modules
5.3.5
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved